Close
Help





JOURNAL

Clinical Medicine Insights: Psychiatry

Metabolic Implications of Psychotropic Medications in a Publicly-Funded State Psychiatric Hospital

Submit a Paper


Clinical Medicine Insights: Psychiatry 2008:1 17-24

Published on 07 Aug 2008


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Psychiatry

Robert G Bota1, Timothy Dellenbaugh2, Andro Giorgadze3, Chadd K Eaglin4 and Cristina Davila1

1Assistant Clinical Professor of Psychiatry, University of Missouri-Kansas City. 2Associate Professor of Psychiatry, University of Missouri-Kansas City. 3Psychiatrist, Middle Flint Behavioral Health Care, Americus, GA. 4Resident Psychiatrist, University of Hawaii.

Abstract

Objective: To assess the metabolic implications for patients admitted to a psychiatric hospital in several patient populations.

Method: Data was collected from the medical records of 108 randomly chosen patients initially diagnosed with schizophrenia and depression in our hospital from 2002 to 2003.

Results:  Weight gain over a one-year period was demonstrated in each group of patients (treated with antipsychotics or antidepressants) (p    0.001). After the implementation of routine lipid panel test, several patients were initially diagnosed with dyslipidemia.

Discussion:  It is important to order routine laboratory work rationally, as this adds to the cost of hospitalization, while considering standard of care recommendations.



Downloads

PDF  (293.38 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services